Saturday, November 1, 2014

Deals

Rosetta Genomics Partners with Admera Health

October 31, 2014 · Leave a Comment 

  Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, announces a collaboration with Admera Health, a spin-off from the clinical services unit of GENEWIZ, Inc., a leading global genomics company. Focused on personalized medicine, Admera Health is a molecular diagnostics company that aims to develop and deliver cost-effective tests that fulfill unmet medical needs, including clinical molecular oncology diagnostics. Under the agreement, Rosetta Genomics will leverage its commercial infrastructure and expertise to market... [Read the full story]

Deal News

Rosetta Genomics Partners with Admera Health

October 31, 2014 · Leave a Comment 

  Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, announces a collaboration with Admera Health, a spin-off from the clinical services unit of GENEWIZ, Inc., a leading global genomics company. Focused on personalized medicine, Admera Health is a molecular diagnostics company that aims to develop and deliver cost-effective tests that fulfill unmet medical needs, including clinical molecular oncology diagnostics. Under the agreement, Rosetta Genomics will leverage its commercial infrastructure and expertise to market... [Read the full story]

Legal

UF, BP settle long-running dispute, though impact to university remains unclear

August 9, 2014 · Leave a Comment 

  A partnership with British Petroleum that should have produced a stream of royalty revenues for the University of Florida for years has evaporated with the stroke of a pen, settling a two-year court battle over $30 million in disputed fees and royalties. The two sides in the intellectual property suit that BP brought against UF quietly reached a settlement agreement over the disputed licensing fees and royalties for a process invented by UF researcher Lonnie Ingram that converts wood pulp into ethanol. A federal judge dismissed the suit in December, reserving the right to bring both sides... [Read the full story]

Bio

Polyplus-transfection and Blue Sky BioServices Sign a Research and Commercial License Agreement

October 29, 2014 · Leave a Comment 

  Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, and Blue Sky BioServices, a contract research organization (CRO) providing Gene Through Screen services for the pharmaceutical and biotechnology R&D market, has announced a non-exclusive, research and commercial license agreement. Polyplus has granted Blue Sky BioServices a licence to use Polyethylenimine (PEI) for in vitro transfection applications. Blue Sky BioServices, has become the 17th sub-licensee, and the 4th CRO to acquire rights from Polyplus to use its... [Read the full story]

University Tech Transfer

The Texas A&M University System and XOMA License Innovative Manufacturing Technology

October 7, 2014 · Leave a Comment 

  COLLEGE STATION, Texas and BERKELEY, Calif., Oct. 6, 2014 (GLOBE NEWSWIRE) — The Texas A&M University System and XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced that the Texas A&M University System agreed to a non-exclusive license for XOMA’s innovative design of a manufacturing facility. The patented technology relates to a flexible arrangement of mobile clean rooms (MCRs) within the manufacturing facility with each MCR providing a portable, self-contained environment that allows for drug development.... [Read the full story]

People

Boulder’s Innovation Center of the Rockies signs commercialization agreement with University of Wyoming

October 11, 2013 · Leave a Comment 

  The Innovation Center of the Rockies, a Boulder-based organization created to help research institutions commercialize technology, has entered into an agreement with the University of Wyoming, officials announced Tuesday. Financial terms of the agreement were not disclosed. The University of Wyoming is the first commercialization partner outside the state of Colorado for the nonprofit Innovation Center of the Rockies, which has inked similar deals with the University of Colorado, Colorado School of Mines, Colorado State University and the University of Denver. “I think that we’ve... [Read the full story]

Deals

Rosetta Genomics Partners with Admera Health

  Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, announces a collaboration with Admera Health, a spin-off from the clinical services unit of GENEWIZ, Inc., a leading global genomics company. Focused on personalized medicine, Admera Health is a molecular diagnostics... Read more of this article


IpVenture Announces Sale of Webvan Patent Portfolio

  LOS ALTOS, Calif., Oct. 29, 2014 /PRNewswire/ –IpVenture, Inc., a patent development and monetization firm, announced today that it has sold the Webvan patent portfolio for an undisclosed sum to a global conglomerate based in Asia. DIAMOND IN THE ROUGH When founded in 1999 during the height of the dot-com bubble, Webvan grew at lightning... Read more of this article


dynaCERT Announces Intellectual Property Acquisition

  TORONTO, ONTARIO–(Marketwired – Oct. 30, 2014) - dynaCERT Inc. (TSX VENTURE:DYA) (“dynaCERT” or the “Company”) is pleased to announce that it has entered into a formal Intellectual Property Transfer Agreement with Sheer Technology Inc. (“Sheer Technology”)in respect of the acquisition by the Company... Read more of this article


Eclipse Aesthetics Acquires International License for Aesthetic Applications of Platelet-Rich Plasma Technology

  Eclipse Aesthetics, LLC, a leader in aesthetic medical devices and supplies, announced today that the company has entered into an exclusive, long-term license to sell and market the platelet-rich plasma (PRP) and platelet-rich fibrin matrix (PRFM) technology from Cascade Medical Enterprises, LLC (CME). The license covers aesthetics, dermatology... Read more of this article


Geometrics announces a Technology License and Development Agreement with Texas Instruments

  Geometrics today announced a Technology License and Development Agreement with Texas Instruments, a significant step in Geometrics efforts to develop miniature atomic magnetometer sensors. Atomic magnetometers are sensitive to extremely small magnetic field changes and are now used primarily in military and geophysical exploration applications.... Read more of this article


Acacia Subsidiary Enters into Settlement and Patent License Agreement with MegaPath Corporation

  NEWPORT BEACH, Calif. — Acacia Research Corporation (NASDAQ: ACTG) announced today that its Brandywine Communications Technologies LLC subsidiary entered into a settlement and patent license agreement with MegaPath Corporation. The agreement resolved litigation that was pending in the United States District Court for the District of Delaware  Read More →


Polyplus-transfection and Blue Sky BioServices Sign a Research and Commercial License Agreement

  Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, and Blue Sky BioServices, a contract research organization (CRO) providing Gene Through Screen services for the pharmaceutical and biotechnology R&D market, has announced a non-exclusive, research and commercial license... Read more of this article


Tipping Point Gaming (TPG) Announces Exclusive License Agreement with WMS

  LAS VEGAS, Oct. 29, 2014 /PRNewswire/ — Tipping Point Gaming (TPG), a pioneer and leading developer of “Picture-In-Picture” (PIP) style systems and applications for the casino gaming industry has announced today that it has signed an exclusive license agreement with WMS Gaming Inc., a wholly owned subsidiary of Scientific Games... Read more of this article


Imprimis Pharmaceuticals Enters into License Agreement for Patented Urology Formulation

  SAN DIEGO, Oct. 29, 2014 /PRNewswire/ – Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY) today announced that it has entered into a license agreement, under which Imprimis acquired the US rights to commercially compound a patented combination of alkalized lidocaine and heparin from Urigen Pharmaceuticals, Inc.  Physicians in the US and abroad... Read more of this article


IpVenture Announces Sale of Webvan Patent Portfolio

  LOS ALTOS, Calif., Oct. 29, 2014 /PRNewswire/ – IpVenture, Inc., a patent development and monetization firm, announced today that it has sold the Webvan patent portfolio for an undisclosed sum to a global conglomerate based in Asia. DIAMOND IN THE ROUGH When founded in 1999 during the height of the dot-com bubble, Webvan grew at lightning... Read more of this article


More Posts From Deals

Legal

UF, BP settle long-running dispute, though impact to university remains unclear

  A partnership with British Petroleum that should have produced a stream of... 


InterDigital Announces Patent License Agreement With Samsung

  WILMINGTON, Del., June 3, 2014 (GLOBE NEWSWIRE) — InterDigital, Inc.... 


More Posts From Legal

University Tech Transfer

The Texas A&M University System and XOMA License Innovative Manufacturing Technology

  COLLEGE STATION, Texas and BERKELEY, Calif., Oct. 6, 2014 (GLOBE NEWSWIRE)... 


Meridian Bioscience and the University of Tennessee Research Foundation Enter into a License Agreement for Electrokinetic Sensor Technology

  CINCINNATI, Aug 06, 2014 (BUSINESS WIRE) — Meridian Bioscience, Inc.... 


More Posts From University Tech Transfer